Skip to main content
Caplight Logo









Genlight Neurotech

Genlight Neurotech

Private
HangzhouHealthcare & Life Scienceshttp://www.genlight.com/

Last Round

Series C

May 12, 2026

Est. Valuation

$1B

Total Funding Raised

$510,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Genlight Neurotech is a medical technology company that develops advanced neurosurgical and brain-computer interface solutions, including laser ablation systems and responsive neurostimulation devices for neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIneuromodulationneurosurgeryclosed-loop neurostimulationlaser interstitial thermal therapyLITTstereotactic EEGSEEGneuro-navigationepilepsy treatmentmedical devicemedtechminimally invasive surgeryneurotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genlight Neurotech Comparables

Compare Genlight Neurotech with similar companies based on industry and business-model similarity.

Genlight Neurotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
景昱医疗科技(苏州)股份有限公司
82%
Beijing PINS Medical Co., Ltd.
76%
NeuroXess
71%

Genlight Neurotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 12, 2026
Series BJan 16, 2022
Series AMar 1, 2021
Pre SeedNov 1, 2020
AngelJun 1, 2020

Key People

Founding team and executive leadership

Peng Cao

Founder CEO

Founding Team

Liangdao Xia

Chief Technology Officer

Executive Team

Genlight Neurotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Reached $1B valuation with Series C round.

  • Jan 16, 2022

    Led by Qiming Venture Partners with participation from CICC Capital, CD Capital, and Yuanjing Capital.

Genlight Neurotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genlight Neurotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genlight Neurotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range4
Year Founded2020
Last FundingMay 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?